Atrial fibrillation (AF) is one of those “if you can recognize it fast, you can score fast” Step topics—because it bridges ECG pattern recognition, hemodynamics, and anticoagulation decision-making. It also shows up everywhere clinically (ED, wards, outpatient), so Step 1 loves to test the underlying mechanisms while Step 2 pushes management and complications.
Quick Definition (What AF is)
Atrial fibrillation is a supraventricular tachyarrhythmia characterized by:
- Chaotic, disorganized atrial electrical activity (often 350–600 impulses/min in the atria)
- Loss of effective atrial contraction (“atrial kick”)
- Irregularly irregular ventricular response due to variable AV nodal conduction
First Aid cross-reference: Cardiovascular → Arrhythmias (Atrial fibrillation: absent P waves, irregularly irregular rhythm; risk of thromboembolism; anticoagulation).
Pathophysiology (Why AF happens)
Think of AF as a problem of triggers + substrate.
1) Triggers: “Where does it start?”
Most commonly, ectopic foci arise near the pulmonary veins (left atrial tissue sleeves). These rapid discharges can initiate AF.
2) Substrate: “Why does it persist?”
Structural/electrical remodeling creates a heart that can sustain AF:
- Atrial dilation (stretch) → reentry circuits more likely
- Fibrosis/inflammation (e.g., chronic HTN, valvular disease) → conduction heterogeneity
- Shortened atrial refractory period (electrical remodeling) → “AF begets AF”
Hemodynamic consequences (Step-relevant)
- Loss of atrial kick → decreased LV filling, especially important in:
- Diastolic dysfunction
- Aortic stenosis
- Hypertrophic cardiomyopathy
- Rapid ventricular rate → decreased diastolic filling time → ↓ cardiac output
- Left atrial appendage stasis → thrombus formation → embolic stroke risk
High-yield mechanism: Thrombi in AF are classically from the left atrial appendage.
Clinical Presentation (How it shows up)
Symptoms vary from none to severe.
Common symptoms
- Palpitations
- Dyspnea, exercise intolerance
- Fatigue
- Chest discomfort
- Lightheadedness
High-yield physical exam
- Irregularly irregular pulse
- Variable intensity of S1 (because diastolic filling varies beat-to-beat)
Dangerous presentations
- Hypotension, altered mental status, ischemic chest pain, acute HF/pulmonary edema
- This is “hemodynamically unstable AF” → treat urgently (see below)
ECG Interpretation: How to diagnose AF in 10 seconds
AF is an ECG diagnosis.
Hallmark ECG findings
- Absent discrete P waves
- Irregularly irregular R-R intervals
- Fibrillatory baseline (fine or coarse “f waves”)
AF vs similar rhythms (high yield)
| Rhythm | P waves? | Regularity | Key clue |
|---|---|---|---|
| Atrial fibrillation | No discrete P waves | Irregularly irregular | Variable R-R, “chaotic” baseline |
| Atrial flutter | Sawtooth flutter waves | Often regular (e.g., 2:1 block) | Atrial rate ~300, consistent pattern |
| Multifocal atrial tachycardia (MAT) | ≥3 P wave morphologies | Irregular | COPD association; P waves present |
| Sinus rhythm w/ PACs | Mostly present | Irregular | Underlying sinus pattern; ectopic beats |
Pearl: If the stem says “irregularly irregular,” assume AF until proven otherwise.
Etiologies & Associations (What Step loves to link)
“Big buckets” of AF causes
- Structural heart disease
- Hypertension → LA enlargement
- Mitral valve disease (esp. stenosis/regurg)
- Heart failure
- Ischemic heart disease
- Endocrine/metabolic
- Hyperthyroidism (classic association)
- Pulmonary
- Pulmonary embolism, hypoxia, COPD (more MAT, but AF can occur)
- Inflammatory
- Myocarditis, pericarditis
- Toxins/meds
- Alcohol (“holiday heart”), stimulants
- Post-op
- Common after cardiac surgery
First Aid-style “buzzword” associations
- Hyperthyroidism → AF
- Mitral stenosis (often rheumatic) → LA enlargement → AF → stroke
- Alcohol binge → “holiday heart” AF
Workup (Step 1 concepts + Step 2 practicals)
Initial evaluation
- 12-lead ECG (confirm rhythm)
- Vitals + hemodynamic stability
- Labs to consider (when looking for reversible triggers):
- TSH (hyperthyroidism)
- Electrolytes (K, Mg)
- Troponin if ischemia suspected
- Echocardiography
- Evaluate structural disease (LA size, valvular disease, EF)
Key clinical decision point: duration
AF is often categorized by duration because it impacts cardioversion strategy:
- <48 hours vs >48 hours/unknown duration
This matters because atrial thrombus risk rises with duration.
Complications (tested relentlessly)
- Thromboembolism → ischemic stroke
- Tachycardia-induced cardiomyopathy (persistent rapid rates)
- Heart failure exacerbation (loss of atrial kick + tachycardia)
High-yield: AF increases risk of stroke even if asymptomatic.
Treatment: The Step Framework
Think of AF management in three parallel lanes:
- Stability (do you need immediate cardioversion?)
- Rate vs rhythm control
- Anticoagulation (stroke prevention)
1) Hemodynamically unstable AF → synchronized cardioversion
If AF + hypotension, shock, ischemia, pulmonary edema, altered mental status:
- Immediate synchronized cardioversion
This is a common Step 2-style “what’s next?” question.
2) Rate control (often first-line in stable patients)
Goal: slow AV nodal conduction and improve filling.
First-line agents
- Beta-blockers (e.g., metoprolol)
- Non-dihydropyridine CCBs: diltiazem or verapamil
Special cases
- Heart failure with reduced EF (HFrEF): prefer beta-blocker or digoxin (CCBs can worsen systolic HF)
- Digoxin
- Helps rate control (vagotonic effect at AV node)
- Less effective during exercise/high sympathetic tone
- Narrow therapeutic index; toxicity concerns
Step 1 tie-in: AV nodal blockers are also used for other SVTs; remember adenosine is for AVNRT/AVRT acute termination, not for converting AF.
3) Rhythm control (conversion/maintenance)
When rhythm control is favored (high-yield indications)
- Persistent symptoms despite adequate rate control
- Younger patients / first episode
- Tachycardia-induced cardiomyopathy
- Difficulty achieving rate control
- Some HF patients where AF is worsening function
Cardioversion options
- Electrical cardioversion
- Pharmacologic cardioversion
- Class Ic (flecainide, propafenone) in selected patients (avoid in structural heart disease)
- Class III (e.g., amiodarone, dofetilide) often used depending on scenario
AF duration and cardioversion safety
If AF is >48 hours or unknown duration:
- Need to address clot risk before cardioversion:
- Anticoagulate for 3 weeks before and 4 weeks after cardioversion OR
- Do TEE-guided cardioversion (if no atrial thrombus seen), then anticoagulate afterward
Why? Restoring atrial contraction can dislodge a pre-existing thrombus → stroke.
Anticoagulation: The high-yield decision-making
AF causes blood stasis in the atria (esp. LAA) → thrombus risk → stroke prevention with anticoagulation when indicated.
Key idea for exams
- Antiplatelet therapy (aspirin) is not adequate stroke prevention for most AF patients compared to anticoagulation.
- Common anticoagulants:
- DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)
- Warfarin (especially in valvular AF—see below)
Valvular vs nonvalvular AF (very testable)
- Valvular AF (classic board meaning): moderate-to-severe mitral stenosis or mechanical heart valve
- Warfarin is preferred
- DOACs are generally not used in mechanical valves; mitral stenosis also classically warfarin
High-Yield AF in Special Scenarios
AF + Wolff-Parkinson-White (WPW)
If AF occurs with an accessory pathway, the AV node is “not the only road” to the ventricles.
ECG clue: AF with wide, bizarre QRS and very fast ventricular rates (pre-excitation).
Do NOT give AV nodal blockers because blocking the AV node can push conduction down the accessory pathway → ventricular fibrillation risk. Avoid:
- Adenosine
- Beta-blockers
- Diltiazem/verapamil
- Digoxin
Treatment (classic teaching):
- Procainamide (or ibutilide) if stable
- Synchronized cardioversion if unstable
This is an extremely high-yield “gotcha.”
Step-Style One-Liners (memorize these)
- AF ECG: No P waves + irregularly irregular rhythm.
- Big complication: Left atrial appendage thrombus → embolic stroke.
- Unstable AF: Immediate synchronized cardioversion.
- AF >48 hours/unknown + cardioversion: Anticoagulate (or TEE first) to prevent stroke.
- AF + WPW: No AV nodal blockers; use procainamide or cardiovert.
- Hyperthyroidism → AF and mitral stenosis → AF are classic associations.
Rapid Review Table: AF at a Glance
| Category | High-yield takeaways |
|---|---|
| Definition | Chaotic atrial activity → ineffective atrial contraction; irregular ventricular response |
| ECG | No discrete P waves; irregularly irregular R-R; fibrillatory baseline |
| Symptoms | Palpitations, dyspnea, fatigue; may be asymptomatic |
| Complications | Stroke (LAA thrombus), HF exacerbation, tachycardia-induced cardiomyopathy |
| Rate control | Beta-blocker or diltiazem/verapamil (avoid non-DHP CCB in HFrEF) |
| Rhythm control | Electrical/pharm cardioversion; consider duration and anticoagulation |
| Anticoag | DOACs often used; warfarin for mechanical valves/mitral stenosis |
| Dangerous exception | AF + WPW → avoid AV nodal blockers; use procainamide or cardioversion |
First Aid Cross-References (where to flip)
Use these as quick anchors while you review:
- Cardiovascular → Arrhythmias: AF ECG pattern + anticoagulation concept
- Cardiovascular → Valvular disease: Mitral stenosis → LA enlargement → AF
- Endocrine → Thyroid disorders: Hyperthyroidism → AF
- Cardiovascular Pharm: AV nodal blockers; antiarrhythmics (Class I/III) and their toxicities (esp. amiodarone)
(Section names may vary slightly by edition, but these are the standard First Aid “homes” for AF.)